Knowledge of metformin-induced vitamin B-12 deficiency and its association with Alzheimer’s disease among medical graduates

Abstract :

Metformin is commonly prescribed as first-line therapy for type 2 diabetes mellitus. Despite its clinical benefit. long-term use has been associated with vitamin B-12 deficiency, which can lead to neurological dysfunction and cognitive disorders, including Alzheimer’s disease. Awareness of this drug-nutrient interaction among healthcare professionals is essential for safe and effective diabetes management. This study evaluated and compared the knowledge of metformin-related vitamin B-12 deficiency and its neurological implications among medical and pharmacy graduates in Libya. A cross-sectional survey was conducted from February to May 2024 among 100 recent graduates (50 medical and 50 pharmacy). The self-designed questionnaire assessed 27 questions that structured knowledge of diabetes pathophysiology, metformin pharmacotherapy, mechanisms of vitamin B-12 deficiency, and its potential association with Alzheimer’s disease. Comparisons were performed using the Chi-square test. Pharmacy graduates demonstrated higher overall knowledge of diabetes management compared with medical graduates (77.2% vs. 66.4%; OR=1.72; p<0.001) and significantly greater awareness of metformin-related complications, particularly vitamin B-12 deficiency. Knowledge regarding metformin-vitamin B-12 interactions and Alzheimer’s disease was comparable between groups. Although most participants recognized dietary sources and monitoring recommendations, inconsistencies were observed in clinical application. Pharmacy graduates demonstrated superior awareness of metformin safety; nevertheless, enduring deficiencies in knowledge across medical and pharmacy graduates indicate a critical need for integrated interprofessional education to advance preventive care and risk mitigation in type 2 diabetes mellitus.

1. Sanhueza L, Durruty P, Vargas C, Vignolo P, Elgueta K. Diabetes mellitus: A group of genetic-based metabolic diseases. Cellular Metabolism and Related Disorders. 2019. doi: 10.5772/intechopen.89924
2. Elmiladi SA. Presentation and character for adult patients with diabetes in Libya. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 79-86. doi: 10.5281/zenodo.6399891
3. Khunti N, Willis A, Davies M, Khunti K. The role of pharmacists in the management of type 2 diabetes: A literature review. Diabetes and Primary Care. 2013; 15(3): 131-140. doi: Nil.
4. Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes mellitus: Insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology. 2021; 2(2): 36-50. doi: 10.3390/diabetology2020004
5. Hadiia GM, Albarasi H, Abdalrahman S, Alasbily HM, Elawamy HA, Alfiturri AM. Metformin dosage and renal protection in type 2 diabetes: Impact on estimated glomerular filtration rate. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(3): 7-14. doi: 10.5281/zenodo.13256137
6. Elmiladi SA, Elgdhafi EO. Prevalence of cardiovascular risk factors in Libyan patients with type 2 diabetes mellitus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(2): 27-33. doi: 10.5281/ zenodo.7877416
7. Alfoghi AMO, Keshlaf SA, Elmiladi SA. Clinical profile of Libyan patients admitted with diabetic ketoacidosis. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4(2): 15-22. doi: 10.5281/zenodo. 11154992
8. Al-Rifai RH, Majeed M, Qambar MA, Ibrahim A, Yammahi KM, Aziz F. Type 2 diabetes and pre-diabetes mellitus: A systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018. Systematic Reviews. 2019; 8(1): 268. doi: 10.3390/diabetology 2020004
9. Elmiladi SA GLP-1RA for glycaemic control and obesity as add-on therapy for type 2 diabetes. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2023; 3(2): 45-50. doi: 10.5281/zenodo.7942952
10. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al. Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences. 2020; 21(17): 6275. doi: 10.3390/ijms 21176275
11. Midhet FM, Al-Mohaimeed AA, Sharaf FK. Lifestyle related risk factors of type 2 diabetes mellitus in Saudi Arabia. Saudi Medical Journal. 2010; 31(7): 768-774. doi: Nil.
12. Schwartz SS, Epstein S, Corkey BE, Grant SFA, Gavin JR, Aguilar RB. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016; 39(2): 179-186. doi: 10.2337/dc15-1585
13. Kim J, Yang S, Lee JI, Chang M. Cardiovascular effect of incretin-based therapy in patients with type 2 diabetes mellitus: systematic review and meta-analysis. PLoS one. 2016; 14; 11(4): e0153502. doi:10.1371/journal. pone.0153502
14. Jamiu MO, Maiha BB, Danjuma NM, Giwa A. Educational intervention on knowledge of hypertension and lifestyle/dietary modification among hypertensive patients attending a tertiary health facility in Nigeria. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2024; 4 (1): 1-11. doi: 10.5281/zenodo. 10535778
15. Landgraf R, Aberle J, Birkenfeld AL, Gallwitz B, Kellerer M, Klein H, et al. Therapy of type 2 diabetes. Experimental and Clinical Endocrinology and Diabetes. 2019; 127(S01): S73-92.doi: 10.1055/a-1018-9106
16. Cappon G, Vettoretti M, Sparacino G, Facchinetti A, Kim MK, Ko SH, et al. Clinical practice guidelines for type 2 diabetes mellitus in Korea. Diabetes and Metabolism Journal. 2019; 43(4): 398-406. doi: 10.4093/dmj. 2019.0137
17. Rizzo G, Laganà AS. A review of vitamin B12. Molecular Nutrition. 2020; 1: 105-129. doi: 10.1016/B978-0-12-811907-5.00005-1
18. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. The New England Journal of Medicine. 2002; 346(7): 476-483. doi: 10.1056/NEJMoa011613
19. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: A review. International Psychogeriatrics. 2012; 24(4): 541-556. doi: 10.1017/S1041610211002511
20. Paul SK. Assessment of knowledge and attitude of adverse drug reactions among healthcare professionals in Bangladesh. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(2): 70-78. doi: 10.5281/ zenodo.15275065
21. Campbell RK. Role of the pharmacist in diabetes management. American Journal of Health-System Pharmacy. 2002; 59(suppl_9): S18-21. doi: 10.1093/ajhp/59.suppl_9.S18
22. Taghizadeh P. The role of pharmacists in managing conditions like hypertension: The case of Northern Cyprus. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(3): 28-37. doi: 10.5281/zenodo. 15921080
23. Hussain MS, Srivastava N, Singh G, Kumar R. Long-term use of metformin and vitamin B12 Deficiency in Diabetes. Current Drug Safety. 2025; 20(3): 258-270. doi: 10.2174/0115748863308106240816044733
24. Kancherla V, Elliott JL Jr, Patel BB, Holland NW, Johnson TM, Khakharia A. Long-term metformin therapy and monitoring for vitamin B12 deficiency among older veterans. Journal of the American Geriatric Society. 2017; 65(5): 1061-1066. doi: 10.1111/jgs.14761
25. Wajid S, Al-Arifi MN, Babelghaith SD, Naqvi A, Althagfan SS, Mahmoud MA. Pharmacy students’ knowledge and attitudes towards diabetes: A cross-sectional study. Biomedical Research. 2018; 29(19): 3638-3642. doi: 10.4066/biomedicalresearch.29-18-1074
26. Powers A, Bardsley JK, Cypress M, Funnell M, Harms D, Hess-Fischl A. Diabetes self-management education and support in adults with type 2 diabetes: A consensus report of the American Diabetes Association, the Association of Diabetes Care and Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAS, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care. 2020; 43(7): 1636-1649. doi: 10.2337/ dci20-0023
27. Kassahun T, Gesesew H, Mwanri L, Eshetie T. Diabetes related knowledge, self-care behaviors and adherence to medications among diabetic patients in Southwest Ethiopia: A cross-sectional survey. BMC Endocrine Disorders. 2016; 31: 16(1): 28. doi: 10.1186/s12902-016-0114-x
28. ElSayed NA, Aleppo G, Bannuru R, Bruemmer D, Collins BS, Ekhlaspour L, et al. Diagnosis and classification of diabetes: Standards of care in diabetes-2024. Diabetes Care. 2024; 47. doi: 10.2337/dc24-S002
29. Bailey CJ. Metformin: Historical overview. Diabetologia. 2017; 60: 1566-1576. doi: 10.1007/s00125-017-4318
30. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015; 38(1): 140-149. doi: 10.2337/dc14-2441
31. Sherif FM. Education and practice of pharmacy in Libya. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(3): 1-2. doi: 10.5281/zenodo.7115078
32. Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C, del Cañizo-Gómez FJ. Update on the treatment of type 2 diabetes mellitus. World Journal of Diabetes. 2016; 7(17): 354-395. doi: 10.4239/wjd.v7.i17.354
33. Perkumpulan Endokrinologi Indonesia (PERKENI). Pedoman pengelolaan dan pencegahan diabetes melitus tipe 2 dewasa di Indonesia. 2021; 4th Ed. Jakarta: PB PERKENI. ISBN: 978-602-530035-5-5
34. Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017; 60(9): 1577-1585. doi: 10.1007/s00125-017-4342-z
35. Kibirige D, Mwebaze R. Vitamin B12 deficiency among patients with diabetes mellitus: Is routine screening and supplementation justified? Journal of Diabetes and Metabolic Disorders. 2013; 12: 17. doi: 10.1186/2251-6581 -12-17
36. Baltrusch S. The role of neurotropic B vitamins in nerve regeneration. BioMed Research International. 2021; 13: 2021. doi: 10.1155/2021/9968228
37. O’Leary F, Samman S. Vitamin B12 in health and disease. Nutrients. 2010; 2(3): 299-316. doi: 10.3390/nu 2030299.
38. de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: Randomized placebo-controlled trial. British Medical Journal. 2010; 340: c2181. doi: 10.1136/bmj.c2181
39. Langan RC, Zawistoski KJ. Update on vitamin B12 deficiency. American Family Physician. 2011; 83(12): 1425-1430. doi: Nil.
40. Niafar M, Hai F, Porhomayon J, Nader ND. The role of metformin on vitamin B12 deficiency: A meta-analysis review. International Emergency Medicine. 2015; 10(1): 93-102. doi: 10.1007/s11739-014-1157-5
41. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. The Journal of Clinical Endocrinology and Metabolism. 2016; 101(4): 1754-1761. doi: 10.1210/jc.2015-3754
42. Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP Jr. Association of biochemical B-12 deficiency with metformin therapy and vitamin B₁₂ supplements: The National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 2012; 35(2): 327-333. doi: 10.2337/dc11-1582
43. Tiwari A, Kumar Singh R, Satone PD, Meshram RJ. Metformin-induced vitamin B12 deficiency in patients with type-2 diabetes mellitus. Cureus. 2023; 15(10): e47771. doi: 10.7759/cureus.47771
44. Shrestha L, Shrestha B, Gautam K, Khadka S, Mahara Rawal N. Plasma vitamin B-12 levels and risk of Alzheimer's disease: A case-control study. Gerontology and Geriatric Medicine. 2022; 8: 23337214211057715. doi: 10.1177/23337214211057715
45. Smith A, Refsum H. Homocysteine and cognition. Annual Review of Nutrition. 2016; 36: 211-239. doi. 10.1146/ annurev-nutr-071715-050947
46. Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. Cognitive impairment and vitamin B12: A review. International Psychogeriatric. 2012; 24(4): 541-556. doi: 10.1017/S1041610211002511
47. Rafi IK, Rahman MM. Factors related to the degree of knowledge regarding hypertension in Kishoreganj, Bangladesh. Mediterranean Journal of Medical Research. 2025; 2(1): 1-5. doi: 10.5281/zenodo.15091123

Citation :

Ibraheim et al. Knowledge of metformin-induced vitamin B-12 deficiency and its association with Alzheimer’s disease among medical graduates. Mediterr J Pharm Sci. 2026; 6(1): 11-20. [Article number: 236]. https://doi.org/10.5281/zenodo.18176820